Show an ad over header. AMP

I am the FIRST!!!

Pfizer raises COVID-19 vaccine sales estimate by 29% to $33.5 billion

Pfizer expects revenue from the COVID-19 vaccine, co-developed by BioNTech, will reach $33.5 billion this year — a 29% jump from the previously estimated $26 billion.

Why it matters: This vaccine, which has dramatically slowed the coronavirus pandemic, is on pace to be the world's top-selling drug of all time, by far. And now Pfizer is pushing for people to get a third "booster" shot of its vaccine to combat the growing Delta variant.


By the numbers: Pfizer registered $7.8 billion of COVID-19 vaccine sales in the second quarter, bringing total worldwide sales so far this year to $11.3 billion.

  • Pfizer expects to deliver 2.1 billion doses this year and has the capacity to manufacture 4 billion doses next year, CEO Albert Bourla said on a conference call.
  • The U.S. previously paid $19.50 per dose for the Pfizer-BioNTech vaccine, but Pfizer recently raised the price to the government to $24 per dose.
  • Flashback: Last year, Bourla said the company would not put a "huge price" on the vaccine, "because that's really taking advantage of a situation, and people will not forget if you do that."

Driving the news: Pfizer said it has new data showing a third dose of its vaccine increases antibody levels significantly against the Delta variant.

  • Pfizer has a financial interest in people, especially Americans, getting a third dose, as it would grow revenues even more.
  • However, epidemiologists have pointed out that higher antibody levels do not mean higher protection, and Pfizer's two-dose schedule is already effective against the coronavirus, including the Delta variant.

The big picture: A majority of the Pfizer-BioNTech vaccine has gone to wealthy countries, whose governments pay higher prices for drugs than lower-income countries.

  • Many lower-income countries have started demanding more doses as their coronavirus cases, hospitalizations and deaths rise.
  • "Africa was largely spared by the pandemic in 2020, but not this year. We lack vaccines, and we are gasping for air," Mosoka Fallah, former director-general of the National Public Health Institute of Liberia, said this week.

What to watch: Moderna reports vaccine sales and earnings Aug. 5.

  • Johnson & Johnson said it expects its COVID-19 vaccine will generate $2.5 billion of sales this year.

regular 4 post ff

infinite scroll 4 pff

Top Democrats fear that protests could help Trump win

Democrats close to Joe Biden increasingly fear the looting and violence in cities could help President Trump, especially among the few undecided or wavering Americans.

Why it matters: This is a huge story that helps explain the state of the race, with some Democrats panicking that Trump could win.

Keep reading...Show less

How climate change feeds off itself and gets even worse

Climate change is like a snowball effect, except, well, hot.

Why it matters: Like a snowball begins small and grows larger by building upon itself, numerous feedback loops embedded in our atmosphere and society are exacerbating climate change.

Keep reading...Show less

UN: 12 million women denied access to birth control due to pandemic

Nearly 12 million women lost access to family planning services including birth control and contraceptives because of the COVID-19 pandemic, the United Nations Population Fund said in a report published Thursday.

Why it matters: The UNPF said the data from 115 low-and-middle-income countries shows the disruption for a total of 3.6 months caused by the pandemic over the past year led to 1.4 million unintended pregnancies.

Keep reading...Show less

A progressive group plans to spend millions connecting green energy to jobs

Progressives are trying to sell President Biden's infrastructure initiative with new cable TV ads arguing clean energy projects will immediately create thousands of jobs.

Why it matters: White House press secretary Jen Psaki suggested Sunday that Biden will split his potential $3 trillion package in two — investments in infrastructure, followed by billions more for the “caregiving economy.” The first political fight may be over what qualifies as infrastructure.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;